GlaxoSmithKline Pharmaceuticals Ltd
IT Refund of Rs 52 crores
REGULATORY
▲ Positive Development
LOW RISK
📅 Filed on BSE: 06 Aug 2026, 07:47 PM IST · BSE ID: adca7db1-576b-4bb3-802f-bcc9f04ab25a
View Original BSE Filing (PDF)
💡
In Simple Terms
The company received a significant tax refund of Rs 52 crore from the government, plus interest.
🤖 AI Summary
- GlaxoSmithKline Pharmaceuticals received a Rs 52.00 Cr tax refund.
- Refund is linked to the assessment for AY 1984-85.
- CIT-Appeal order received on January 27, 2026.
- Rs 42.09 Cr interest income will be credited to P&L.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Refund Amount
Rs 52.00 Cr
Interest Income
Rs 42.09 Cr
CIT-Appeal Order Date
27th Jan, 2026
Refund Received Date
6th Aug, 2026
🏢 How This Affects the Company
The company will book Rs 42.09 Cr as interest income in its profit and loss account. The receipt of Rs 52.00 Cr will bolster the company's cash reserves.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this refund receipt.
👤
Who Is Affected
All shareholders are indirectly affected by the improved cash position and accounting income arising from this refund.
🔍
Management Signal
This confirms management's successful resolution of past tax liabilities and claims.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarterly results announcement for impact on P&L.
Review of cash flow statement for cash impact.
Tax filings for AY 1984-85 closure confirmation.
LOW RISK
The filing details a completed tax refund and income recognition, posing no new or immediate risks.
💡 Investor Takeaway
GlaxoSmithKline Pharmaceuticals received a Rs 52.00 Cr tax refund and will book Rs 42.09 Cr interest income, resolving a tax matter from assessment year 1984-85.
⚖️ Strengths & Concerns
✅ Positives
- Receipt of Rs 52.00 Cr tax refund from the Income Tax department.
- Anticipated credit of Rs 42.09 Cr interest income to the P&L account.
❓ Frequently Asked Questions
What is the total tax refund received by GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals has received a total tax refund of Rs 52.00 Cr.
What assessment year is the tax refund related to?
The tax refund is related to the assessment year 1984-85.
How much interest income will GlaxoSmithKline Pharmaceuticals credit?
The company will credit Rs 42.09 Cr as interest income on the refund to its P&L account.
When was the CIT-Appeal order received?
The order from the CIT-Appeal was received on January 27, 2026.
Questions based on this BSE filing only. For information purposes.